Medical
Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
CAMBRIDGE, Mass., May 14 /PRNewswire-FirstCall/ — Biopure Corporation today announced that the results from its Phase II coronary revascularization trial have been published in the peer-reviewed EuroIntervention Journal. The paper is entitled “Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design, and haemodynamic results.” […]
Maryland Approves Medicaid Reimbursement for ActiPatch(R)
FREDERICK, Md., April 21 /PRNewswire/ — Maryland Medicaid has approved medical necessity product reimbursement for ActiPatch(TM) for kidney-compromised patients. BioElectronics Corporation, (Pink Sheets: BIEL), is the maker of ActiPatch, a revolutionary drug-free anti-inflammatory patch which accelerates healing.Many commonly used pharmaceutical agents including aspirin, ibuprofen (Advil, Motrin, Nuprin) and Naproxen (Aleve, Anaprox, Naprosyn) with regular […]
